Dan has an undergraduate degree in both Biology and Chemistry and received his Ph.D. in pharmaceutics and medicinal chemistry in 2009, from the school of pharmacy at the Hebrew University of Jerusalem, Israel. In his research Dan worked on developing novel drugs for the treatment of epilepsy and neuropathic pain. This work has led to the development of a novel drug, sec-Butyl propylacetamide (SPD), currently in pre-clinical trials for the treatment of epilepsy, pain disorders and migraine. Dan proceeded to do his post-doctoral fellowship in the anticonvulsant drug development (ADD) program where he pursued the potential of SPD as a future drug.
Dan has always been intrigued by the healing arts in regard to pain management and understanding cognitive and emotional processes and their connection to the human body. This passion has led him to pursue other disciplines remote from science such as neuro-linguistic programming (NLP) and hypnosis. Dan is a master practitioner in NLP, and is a Certified Clinical Hypnotherapist approved by the American Council of Hypnotist Examiners (A.C.H.E).
Presently, Dan is working in the University of Utah as a research scientist studying stress induced migraine in males vs. females and is working to include hypnotherapy in the university migraine clinic.